scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10038-006-0029-X |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10038-006-0029-x |
P698 | PubMed publication ID | 16897188 |
P5875 | ResearchGate publication ID | 6890357 |
P50 | author | CS Chim | Q64761563 |
P2093 | author name string | R Liang | |
K F Wong | |||
T K Fung | |||
J S Lau | |||
P2860 | cites work | Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status | Q28143274 |
The INK4a/ARF network in tumour suppression | Q28190064 | ||
A gene hypermethylation profile of human cancer | Q28213253 | ||
Hypermethylation of gene promoters in hematological neoplasia | Q28216777 | ||
The biochemistry of apoptosis | Q29547741 | ||
Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma | Q31984891 | ||
Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. | Q34327110 | ||
TP53 in hematological cancer: low incidence of mutations with significant clinical relevance | Q35078753 | ||
Biology and treatment of chronic lymphocytic leukemia | Q35591429 | ||
Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients | Q35770277 | ||
Intrinsic tumour suppression | Q35953133 | ||
SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway | Q38344554 | ||
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). | Q40420609 | ||
Methylation profiling in multiple myeloma. | Q40514855 | ||
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation | Q40833586 | ||
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells | Q40854057 | ||
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. | Q40949835 | ||
Cytogenetics in chronic lymphocytic leukemia. | Q41712556 | ||
Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. | Q44243321 | ||
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients | Q44791847 | ||
Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia | Q46766310 | ||
Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase | Q47445275 | ||
Cancer statistics, 1997. | Q50980276 | ||
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. | Q54755048 | ||
The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 cases | Q71997303 | ||
Expression of p16INK4A and p14ARF in hematological malignancies | Q73171012 | ||
Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance | Q73703062 | ||
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance | Q74046091 | ||
Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patients | Q77747520 | ||
Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia | Q82329418 | ||
P433 | issue | 9 | |
P921 | main subject | leukemia | Q29496 |
lymphocyte | Q715347 | ||
hypermethylation | Q106875739 | ||
P304 | page(s) | 832-838 | |
P577 | publication date | 2006-08-03 | |
P1433 | published in | Journal of Human Genetics | Q6295302 |
P1476 | title | Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia | |
P478 | volume | 51 |
Q81079624 | Aberrant gene promoter methylation in plasma cell dyscrasias |
Q46060620 | CpG island methylation patterns in chronic lymphocytic leukemia |
Q38060723 | DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas. |
Q38343779 | DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. |
Q33285707 | Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing |
Q36287377 | Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia |
Q37424922 | Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway |
Q37616347 | Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. |
Q36621405 | Epigenetic inactivation of the MIR129-2 in hematological malignancies. |
Q31008825 | Epigenetic inactivation of the miR-124-1 in haematological malignancies |
Q39745821 | Epigenetic inactivation of the miR-34a in hematological malignancies |
Q37696142 | Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia. |
Q36688994 | Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways. |
Q38889464 | Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma. |
Q46864071 | Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma. |
Q36981741 | Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes |
Q24646541 | Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes |
Q34413764 | Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients. |
Search more.